News | November 10, 2021
US govt places additional order of 1.4 million courses of molnupiravir
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
Glycopyrrolate injection can also be used in adults as an adjunctive therapy for the treatment of gastrointestinal ulcer when a rapid effect is desired or when oral medication is not tolerated
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
It provides an option to automatically perform nodule detection immediately after chest X-ray imaging
Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021
The NFI is published to promote the rational use of medicines in the country.
Moderate-to-severe plaque psoriasis affects about 35 per cent of patients. A key challenge is that many treatments stop working overtime and symptoms return
Acute therapies continue to report strong growth compared to chronic ones.
Subscribe To Our Newsletter & Stay Updated
